J&S Studies, Inc.

New Brighton, Minnesota 55112

0 studies enrolling now · 1 studies all time

What they study most

Atopic Dermatitis (AD)

Studies at this site

• Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment With 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis — Completed